What is the criteria to identify individuals who may benefit from a moderate- to high-intensity statin therapy?
Individuals who may benefit from a moderate- to high-intensity statin therapy are those with intermediate ASCVD risk (7.5% to 20%), a primary elevation of LDL-C 160 mg/dL (4.1 mmol/L), metabolic syndrome, inflammatory diseases (including psoriasis and RA), and HIV when treated with protease inhibitors. Additionally, women with a history of pregnancy complicated by preeclampsia or premature menopause (age <40 years) may also benefit from statin therapy.